Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1Other neoplasm 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Follicular 17Lymphoma, B-Cell, Marginal Zone 17Leukemia, Myeloid, Acute 17Congenital Abnormalities 17Breast Neoplasms 16Lymphoma, Mantle-Cell 15Leukemia 15Lymphoma, Non-Hodgkin 14Lymphoma, Large B-Cell, Diffuse 14Multiple Myeloma 12Lymphoma, Large-Cell, Immunoblastic 11Lymphoma 11Burkitt Lymphoma 11Blast Crisis 11Myeloproliferative Disorders 10Myelodysplastic Syndromes 10Lymphoma, T-Cell, Cutaneous 10Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Accelerated Phase 10Sezary Syndrome 9Mycosis Fungoides 9Leukemia, Myeloid, Chronic-Phase 9Waldenstrom Macroglobulinemia 8Lymphoma, Large-Cell, Anaplastic 8Hodgkin Disease 8Primary Myelofibrosis 7Pdgfra-Associated Chronic Eosinophilic Leukemia 6Neoplasms, Plasma Cell 6

Interventions

Colposcopy 15Imiquimod 13Conization 11Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7Cryotherapy 7Papillomavirus Vaccines 6Biopsy 6Acetic Acid 6human papillomavirus vaccine, L1 type 16, 18 5Vaginal Smears 5Watchful Waiting 4Human Papillomavirus DNA Tests 4Vaccines 3Blood Specimen Collection 3VGX-3100 2Transurethral Resection of Prostate 2Spectrometry, Fluorescence 2Restraint, Physical 2Proflavine 2Polymerase Chain Reaction 2Mass Screening 2Indomethacin 2Human Papillomavirus Recombinant Vaccine nonavalent 2High-Throughput Screening Assays 2GX-188 vaccine 2Fluorouracil 2Flow Cytometry 2Cyclophosphamide 2Curcumin 2Celecoxib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Uterine Cervical Dysplasia × Flow Cytometry × Clear all
NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

University Health Network, Toronto

Phase 1 Terminated
BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

NCT00629577 2017-02-01

SAGE

British Columbia Cancer Agency

Phase 1 Terminated
50 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡